Skip to main content

Advertisement

Log in

Wolfram syndrome: clinical and genetic profiling of a cohort from a tertiary care centre with characterization of the primary gonadal failure

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

Wolfram syndrome (WFS) is a rare, monogenic neurodegenerative syndrome characterised by insulin requiring non-autoimmune diabetes mellitus (DM) and optic atrophy which are usually the earliest and commonest manifestations. However, there are other features which are under-recognized, adding to morbidity and premature mortality in these patients.

Methods

Five patients (three males, two females) with genetically confirmed WFS at a single tertiary care centre were prospectively followed up. Their symptomatology, clinical profile, genetic analysis and radiology were analyzed. Multidisciplinary approach was used for comprehensive clinical care of this cohort. Patients with primary gonadal failure were subjected to biopsy and immunohistochemistry (IHC) for wolframin was performed.

Results

DM was the earliest presenting manifestation at 6.2 ± 1.3 years followed by optic atrophy at 10.4 ± 2.3 years, diabetes insipidus at 12 ± 2.1 years and deafness at 12.8 ± 2.1 years. All patients were autoantibody negative with low C-peptide(<0.6 ng/ml). Hypoglycemic episodes were frequent (upto 60%) but there was no instance of diabetic ketoacidosis. Optic atrophy was present alongwith proliferative diabetic retinopathy and cataract in 40%. Uncommon manifestations included neuropsychiatric features, parasuicide, cystopathy, brainstem atrophy and hypergonadotropic hypogonadism only in adult males (n = 2). Testicular biopsy revealed partly hyalinised seminiferous tubules and prominence of Leydig cells. IHC confirmed the presence of mutated wolframin, which was not significantly different from normal testis specimen on protein quantification.

Conclusions

WFS requires a multidisciplinary approach with special emphasis on early diagnosis and management of other endocrine and non-endocrine features so as to improve long-term outcomes. Gonadal functions need periodic assessment, especially in adult males.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

WFS:

Wolfram syndrome

DIDMOAD:

Diabetes insipidus, Diabetes mellitus, Optic atrophy, Deafness

IHC:

Immunohistochemistry

DR:

Diabetic retinopathy

PDR:

Proliferative diabetic retinopathy

TRD:

Tractional retinal detachment

OA:

Optic atrophy

ELISA:

Enzyme linked immunosorbent assay

ECLIA:

Electrochemiluminescence assay

RD:

Retinal detachment

PRP:

Panretinal photocoagulation

SNHL:

Sensorineural hearing loss

GAD:

Glutamic acid decarboxylase

PTA:

Pure tone audiogram

BERA:

Brainstem evoked response audiometry

LH:

Luteinizing hormone

FSH:

Follicle stimulating hormone

H&E:

Hematoxylin and eosin

DM:

Diabetes mellitus

UPR:

Unfolded protein response

ER stress:

Endoplasmic reticulum stress

AIP:

Aryl hydrocarbon receptor interacting protein

HbA1c:

Glycated hemoglobin

DKA:

Diabetic ketoacidosis

SMBG:

Self-monitoring of blood glucose

HGMD:

Human gene mutation database

SSRI:

Selective serotonin reuptake inhibitors

References

  1. J. Rohayem, C. Ehlers, B. Wiedemann, R. Holl, K. Oexle, O. Kordonouri, G. Salzano, T. Meissner, W. Burger, E. Schober, A. Huebner, Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype. Diabetes Care 34(7), 1503–1510 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. D. Wolfram, H. Wagener, Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin. Proc. 13, 715–718 (1938)

    Google Scholar 

  3. L. Rigoli, F. Lombardo, C. Di Bella, Wolfram syndrome and WFS1 gene. Clin. Genet. 79(2), 103–17. (2011)

    Article  CAS  PubMed  Google Scholar 

  4. K. Ajlouni, N. Jarrah, M. El‐Khateeb, M. El‐Zaheri, H. El Shanti, A. Lidral, Wolfram syndrome: identification of a phenotypic and genotypic variant from Jordan. Am. J. Med. Genet. 115(1), 61–65 (2002)

    Article  PubMed  Google Scholar 

  5. M.L. de Heredia, R. Clèries, V. Nunes, Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet. Med. 15(7), 497–506 (2013)

    Article  PubMed  Google Scholar 

  6. T.G. Barrett, S.E. Bundey, A.F. Macleod, Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346, 1458–1463 (1995)

    Article  CAS  PubMed  Google Scholar 

  7. R.G. Swift, D.B. Sadler, M. Swift, Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336(8716), 667–669 (1990)

    Article  CAS  PubMed  Google Scholar 

  8. D. Gupta, P. Bhai, R. Saxena, S. Bijarnia-Mahay, R.D. Puri, Spectrum of mutations in WFS1 gene in six families with Wolfram syndrome: identification of five novel mutations. J. Mol. Genet Med. 12(380), 1747–0862 (2018)

    Google Scholar 

  9. A. Zmysłowska, M. Borowiec, W. Fendler, P. Jarosz-Chobot, M. Myśliwiec, A. Szadkowska, W. Młynarski, The prevalence of Wolfram syndrome in a paediatric population with diabetes. EndokrynologiaPolska 65(4), 295–297 (2014)

    Google Scholar 

  10. A. Cano, L. Molines, R. Valéro, G. Simonin, V. Paquis-Flucklinger, B. Vialettes, Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age-and duration-matched comparison with common type 1 diabetes. Diabetes Care 30(9), 2327–2330 (2007)

    Article  CAS  PubMed  Google Scholar 

  11. A. Karasik, C. O’Hara, S. Srikanta, M. Swift, J.S. Soeldner, C.R. Kahn, R.D. Herskowitz, Genetically programmed selective islet β-cell loss in diabetic subjects with Wolfram’s syndrome. Diabetes Care 12(2), 135–138 (1989)

    Article  CAS  PubMed  Google Scholar 

  12. S. Hofmann, C. Philbrook, K.D. Gerbitz, M.F. Bauer, Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum. Mol. Genet. 12(16), 2003–2012 (2003)

    Article  CAS  PubMed  Google Scholar 

  13. D. Abreu, R. Asada, J. M. Revilla, Z. Lavagnino, K. Kries, D. W. Piston, F. Urano, Wolfram syndrome 1 gene regulates pathways maintaining beta-cell health and survival. Laboratory Investigation. 1–4 (2020). https://doi.org/10.1038/s41374-020-0408-5. [Epub ahead of print]

  14. S.G. Fonseca, M. Fukuma, K.L. Lipson, L.X. Nguyen, J.R. Allen, Y. Oka, F. Urano, WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic β-cells. J. Biol. Chem. 280(47), 39609–39615 (2005)

    Article  CAS  PubMed  Google Scholar 

  15. B. Delprat, T. Maurice, C. Delettre, Wolfram syndrome: MAMs’ connection? Cell Death Dis. 9(3), 364 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  16. M.A. Buryk, K. Bangalore-Krishna, M. Rivera-Vega, L. Garibaldi, Wolfram syndrome: are we aware of the severe hypoglycemic unawareness? J. Diabetes Res. Clin. Metab. 2(1), 4 (2013)

    Article  Google Scholar 

  17. M. Scaramuzzi, P. Kumar, N. Peachey, P. Nucci, E.I. Traboulsi, Evidence of retinal degeneration in Wolfram syndrome. Ophthalmic Genet. 40(1), 34–38 (2019)

    Article  PubMed  Google Scholar 

  18. M. Al-Till, N.S. Jarrah, K.M. Ajlouni, Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur. J. Ophthalmol. 12(2), 84–88 (2002)

    Article  CAS  PubMed  Google Scholar 

  19. B.T. Gabreëls, D.F. Swaab, D.P. De Kleijn, A. Dean, N.G. Seidah, J.W. Van de Loo, W.J. Van de Ven, G.J. Martens, F.W. Van Leeuwen, The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J. Clin. Endocrinol. Metab. 83(11), 4026–4033 (1998)

    Article  PubMed  Google Scholar 

  20. R. Karzon, A. Narayanan, L. Chen, J.E. Lieu, T. Hershey, Longitudinal hearing loss in Wolfram syndrome. Orphanet J. rare Dis. 13(1), 102 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  21. G.E. Bueno, D. Ruiz-Castañeda, J.R. Martínez, M.R. Muñoz, P.C. Alascio, Natural history and clinical characteristics of 50 patients with Wolfram syndrome. Endocrine 61(3), 440–446 (2018)

    Article  CAS  PubMed  Google Scholar 

  22. M.R. Homan, B.R. Mackay, Primary hypogonadism in two siblings with Wolfram syndrome. Diabetes Care 10(5), 664–665 (1987)

    Article  CAS  PubMed  Google Scholar 

  23. T.G. Barrett, S.E. Bundey, Wolfram (DIDMOAD) syndrome. J. Med. Genet. 34, 838–841 (1997)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. K. Noormets, S. Kõks, A. Kavak, A. Arend, M. Aunapuu, A. Keldrimaa, E. Vasar, V. Tillmann, Male mice with deleted Wolframin (Wfs1) gene have reduced fertility. Reprod. Biol. Endocrinol. 7(1), 82 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  25. J.M. Van Den Ouweland, K. Cryns, R.J. Pennings, I. Walraven, G.M. Janssen, J.A. Maassen, B.F. Veldhuijzen, A.B. Arntzenius, D. Lindhout, C.W. Cremers, G. Van Camp, Molecular characterization of WFS1 in patients with Wolfram syndrome. J. Mol. Diagn. 5(2), 88–95 (2003)

    Article  Google Scholar 

  26. M.L. Jaffrain-Rea, M. Angelini, D. Gargano, M.A. Tichomirowa, A.F. Daly, J.F. Vanbellinghen, E. D’Innocenzo, A. Barlier, F. Giangaspero, V. Esposito, L. Ventura, Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr. Relat. Cancer 16(3), 1029–1043 (2009)

    Article  CAS  PubMed  Google Scholar 

  27. C.A. Leontiou, M. Gueorguiev, J. Van Der Spuy, R. Quinton, F. Lolli, S. Hassan, H.S. Chahal, S.C. Igreja, S. Jordan, J. Rowe, M. Stolbrink, The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J. Clin. Endocrinol. Metab. 93(6), 2390–2401 (2008)

    Article  CAS  PubMed  Google Scholar 

  28. M. Swift, R.G. Swift, Wolframin mutations and hospitalization for psychiatric illness. Mol. psychiatry 10(8), 799 (2005)

    Article  CAS  PubMed  Google Scholar 

  29. S. Lodha, L. Das, G. D. Ramchandani, A. Bhansali, A case of young diabetes and parasuicide. Case Reports. bcr-2018-225839 (2018)

  30. F. Urano, Wolfram syndrome: diagnosis, management, and treatment. Curr. diabetes Rep. 16(1), 6 (2016)

    Article  Google Scholar 

  31. H.M. Lugar, J.M. Koller, J. Rutlin, S.A. Eisenstein, O. Neyman, A. Narayanan, L. Chen, J.S. Shimony, T. Hershey, Evidence for altered neurodevelopment and neurodegeneration in Wolfram syndrome using longitudinal morphometry. Sci. Rep. 9(1), 6010 (2019)

    Article  PubMed  PubMed Central  Google Scholar 

  32. J.B. Hilson, S.N. Merchant, J.C. Adams, J.T. Joseph, Wolfram syndrome: a clinicopathologic correlation. Actaneuropathologica 118(3), 415–428 (2009)

    Google Scholar 

  33. S. Ito, R. Sakakibara, T. Hattori, Wolfram syndrome presenting marked brain MR imaging abnormalities with few neurologic abnormalities. Am. J. Neuroradiol. 28(2), 305–306 (2007)

    CAS  PubMed  Google Scholar 

  34. R. Wragg, R.P. Dias, T. Barrett, L. McCarthy, Bladder dysfunction in Wolfram syndrome is highly prevalent and progresses to megacystis. J. Pediatr. Surg. 53(2), 321–325 (2018)

    Article  PubMed  Google Scholar 

  35. E. Simsek, T. Simsek, S. TekgüT, S. Hosal, V. Seyrantepe, G. Aktan, Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature. Acta Paediatr 92(1), 55–61 (2003)

    Article  CAS  PubMed  Google Scholar 

  36. C. Rouzier, D. Moore, C. Delorme, S. Lacas-Gervais, S. Ait-El-Mkadem, K. Fragaki, F. Burté, V. Serre, S. Bannwarth, A. Chaussenot, M. Catala, A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions. Hum. Mol. Genet. 26(9), 1599–1611 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. M. Cattaneo, L. La Sala, M. Rondinelli, E. Errichiello, O. Zuffardi, A.A. Puca, S. Genovese, A. Ceriello, A donor splice site mutation in CISD2 generates multiple truncated, non-functional isoforms in Wolfram syndrome type 2 patients. BMC Med. Genet. 18(1), 147 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  38. H. K. Akturk, S.Yasa, Previously unreported abnormalities in Wolfram Syndrome Type 2. Pediatric Endocrinol. Diabetes Metabolism. 23(2), 111–116 (2017)

    Google Scholar 

Download references

Acknowledgement

We are indebted to Prof RJ Dash, our teacher and an esteemed endocrinologist in his own right, who edited and provided invaluable suggestions for improvement of the manuscript. We would also like to sincerely thank all the patients and their families for their support, understanding and patience.

Author information

Authors and Affiliations

Authors

Contributions

L.D. did data collection and analysis, patient management, follow-up, drafted the manuscript and did literature review. A.R. performed immunohistochemistry of wolframin and helped in drafting the manuscript. R.M. did gonadal biopsy of patients. K.V. interpreted the histopathology and immunohistochemistry in samples of patients and controls. A.S. did psychological evaluation for patients. V.G. performed ophthalmologic evaluation and fundus photography. S.K.B. supervised patient management and edited the manuscript. S.L. helped patient management. N.P. performed audiologic evaluation of the patients. A.B. oversaw patient management and edited the manuscript. P.S. provided radiologic expertise for the patients. P.D. conceived the idea, supervised patient management and follow-up, designed the experiments, interpreted results and edited the manuscript.

Corresponding author

Correspondence to Pinaki Dutta.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional ethical committee clearance was obtained (IEC/2020/002784/SPL-149).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Das, L., Rai, A., Mavuduru, R. et al. Wolfram syndrome: clinical and genetic profiling of a cohort from a tertiary care centre with characterization of the primary gonadal failure. Endocrine 69, 420–429 (2020). https://doi.org/10.1007/s12020-020-02320-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02320-6

Keywords

Navigation